1R42 image
Entry Detail
PDB ID:
1R42
Keywords:
Title:
Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2)
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2003-10-07
Release Date:
2004-02-03
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.28
R-Value Work:
0.23
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:angiotensin I converting enzyme 2
Chain IDs:A
Chain Length:615
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:disordered segment of collectrin homology domain
Chain IDs:B
Chain Length:6
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:disordered segment of collectrin homology domain
Chain IDs:C
Chain Length:20
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:disordered segment of collectrin homology domain
Chain IDs:D
Chain Length:18
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:disordered segment of collectrin homology domain
Chain IDs:E
Chain Length:14
Number of Molecules:1
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN A ASN GLYCOSYLATION SITE
Primary Citation

Abstact

The angiotensin-converting enzyme (ACE)-related carboxypeptidase, ACE2, is a type I integral membrane protein of 805 amino acids that contains one HEXXH + E zinc-binding consensus sequence. ACE2 has been implicated in the regulation of heart function and also as a functional receptor for the coronavirus that causes the severe acute respiratory syndrome (SARS). To gain further insights into this enzyme, the first crystal structures of the native and inhibitor-bound forms of the ACE2 extracellular domains were solved to 2.2- and 3.0-A resolution, respectively. Comparison of these structures revealed a large inhibitor-dependent hinge-bending movement of one catalytic subdomain relative to the other (approximately 16 degrees) that brings important residues into position for catalysis. The potent inhibitor MLN-4760 ((S,S)-2-[1-carboxy-2-[3-(3,5-dichlorobenzyl)-3H-imidazol4-yl]-ethylamino]-4-methylpentanoic acid) makes key binding interactions within the active site and offers insights regarding the action of residues involved in catalysis and substrate specificity. A few active site residue substitutions in ACE2 relative to ACE appear to eliminate the S(2)' substrate-binding subsite and account for the observed reactivity change from the peptidyl dipeptidase activity of ACE to the carboxypeptidase activity of ACE2.

Legend

Protein

Chemical

Disease

Primary Citation of related structures